Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001698284 | SCV000532164 | likely benign | not provided | 2019-05-03 | criteria provided, single submitter | clinical testing | |
Center for Human Genetics, |
RCV000659357 | SCV000781168 | likely benign | Connective tissue disorder | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001471006 | SCV001675108 | likely benign | Osteogenesis imperfecta type I | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002279205 | SCV002565513 | uncertain significance | Ehlers-Danlos syndrome | 2020-03-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002446732 | SCV002611753 | likely benign | Cardiovascular phenotype | 2022-08-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |